Currently there are several licensed drugs and small molecules which target NA [89], such as neuraminidase inhibitors (NAIs) [90], strongly suggesting that a vaccine capable of eliciting anti-NA responses would be beneficial to preventing disease from influenza. The gene discussed is XK; the disease is influenza.